Moving Medicine Forward
The Division of Hematology (Ottawa Blood Disease Centre), Department of Medicine of The Ottawa Hospital/University of Ottawa is experiencing significant clinical and academic growth. We are seeking a hematologist to join our Lymphoma Program as well as in our expansion, and to lead in clinical care, education and research as a full-time faculty member.
The lymphoproliferative group currently consists of 6 faculty who see >600 new lymphoma and CLL patients per year, offers a clinical lymphoma fellowship program, and conducts a mix of clinical research activities. The Lymphoproliferative Disease Group partners with the Transplant and Cell Therapy program to provide hematopoietic cell transplants and immune effector cell therapies, with both commercial and research product activity. All faculty in the Malignant Hematology Program are co-located at the General Campus of The Ottawa Hospital.
The Ottawa Blood Disease Centre is a large group of 41 faculty that work within a group practice plan model within the University of Ottawa and The Ottawa Hospital academic centre. The Division has three well-defined and successful clinical and research programs: Malignant Hematology, Thrombosis and Benign Hematology. The 20+ faculty members in The Malignant Hematology, Transplant and Cellular Therapy programs work within well-defined and integrated clinical and research groups, with a variety of academic pursuits.
The Ottawa Hospital is a 1150 bed tertiary-care hospital serving Eastern Ontario and Western Quebec at four inpatient sites (Civic, General, Heart Institute, and the Rehabilitation Centre) and one ambulatory centre (Riverside). There are approximately 50,000 inpatient admissions, 160,000 emergency visits and over one million outpatient visits annually.
The Ottawa Hospital Research Institute (OHRI) is TOH’s research arm. It ranks fourth out of more than 600 Canadian hospitals for competitive, peer-reviewed grants from the prestigious Canadian Institutes of Health Research. OHRI houses over 2,200 researchers, publishing more than 2,000 studies yearly, with hundreds being high impact publications (top 10% or citations) and places 5th overall in Canada for research funding.
The Department of Medicine is a research-intensive Department. Members currently hold 28 University Research Chairs. The Department receives approximately $60 million per year in external research funding and members publish approximately 1200 peer-reviewed publications annually.
The Faculty of Medicine is a nationally recognized leader, ranked among Canada’s top-tier medical faculties. The Faculty ranks 3rd in Canada for research intensity in Medicine/Science (Maclean’s) and 4th in Canada for citations (2022 THE rankings). The University of Ottawa is the largest bilingual (English-French) university in the world and the first and largest bilingual medical school in Canada. The Faculty of Medicine has a long history of conducting the highest quality basic and clinical research, in close partnership with affiliated hospitals and research institutes. The Web of Science recently published a list of the most highly cited researchers in the world, where seven out of eight researchers identified from the uOttawa are from the Faculty of Medicine. Together, these remarkable achievements are a strong testament to the competitiveness and excellence of our Faculty.
The Lymphoproliferative Disease Group is looking to enhance academic productivity to complement the existing excellent clinical program and academic activities. To facilitate this, we are recruiting 2 academically focused early or mid-career lymphoma hematologists who are looking for the opportunity to join a supportive group with 50% protected time for academic pursuits. Fellows completing their lymphoma fellowship and interested trainees are encouraged to apply.
In addition to the resources available within the Division of Hematology which include a Clinical Research Office, the Ottawa Hospital Research Institute houses experts in broad areas of clinical epidemiology, statistical support, transfusion medicine research, patient decision making, knowledge translation. The successful candidate will be supported and mentored to pursue a mutually agreed area of clinical research or quality improvement that fits their interests.
The successful candidate must hold an MD degree; have, or be eligible for certification in Hematology by the Royal College of Physicians and Surgeons of Canada with expertise in lymphoproliferative diseases; be a member of, or be eligible to be a member of, the Canadian Medical Protective Association; have, or be eligible for, licensure in Ontario; and, be eligible for a University of Ottawa academic appointment. The successful candidate will have training in keeping with an academic position that includes enhanced protected time for research or quality improvement.
The University of Ottawa and The Ottawa Hospital are bilingual institutions and therefore in the case of potentially successful candidates of equal ability, a bilingual (French/English) candidate would be preferred.
The Department of Medicine is committed to ensuring equity, diversity and inclusion in our work environment. We strongly encourage applications from Indigenous persons, visible minorities members (racialized persons), persons with disabilities, women, as well as from all qualified candidates with the skills and knowledge to productively engage with equitable, diverse and inclusive communities. We encourage qualified applicants from all groups with historical and/or current barriers to equity to apply. Upon request, accommodations due to a disability are available throughout the recruitment process.
Please note Canadian citizens and permanent residents will be given priority. We sincerely thank all applicants for their interest; however, only those selected for an interview will be contacted.
The position is part of a provincial Alternate Funding Plan (AFP), with salary and benefits that are competitive nationally. Income is derived from a variety of sources including but not limited to clinical billings (fee-for-service), salary support (AFP) as well as honorariums/stipends. Health and welfare benefits including extended health, dental and disability insurance as well as life insurance are offered to full-time physicians.
Please forward a 1-2 page letter of intent, 3 references (who will not be contacted without permission) and a CV to Dr Marc Carrier, Head Division of Hematology, Department of Medicine The Ottawa Hospital and University of Ottawa at \"">.